Add-on Acquisition • Medical Products

Cantel Medical Acquires Accutron

On August 1, 2016, Cantel Medical acquired medical products company Accutron for 53M USD

Acquisition Context
  • This is Cantel Medical’s 9th transaction in the Medical Products sector.
  • This is Cantel Medical’s 7th largest (disclosed) transaction.
  • This is Cantel Medical’s 8th transaction in the United States.
  • This is Cantel Medical’s 1st transaction in Connecticut.

Explore All 2731 Add-on Acquisition Medical Products Deals - Search the Database Free


M&A Deal Summary

Date August 1, 2016
Target Accutron
Sector Medical Products
Buyer(s) Cantel Medical
Deal Type Add-on Acquisition
Deal Value 53M USD

Target Company

Accutron

Windsor, Connecticut, United States
Accutron, Inc. is a manufacturer of nitrous oxide delivery systems and single-use nasal masks.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Cantel Medical

Little Falls, New Jersey, United States

Category Company
Founded 1963
Sector Medical Products
Revenue 1.0B USD (2020)
DESCRIPTION

Cantel Medical Corp. is a provider of medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products. Cantel Medical was formed in 1963 and is based in Little Falls, New Jersey.


Deal Context for Buyer #
Overall 12 of 20
Sector: Medical Products 9 of 15
Type: Add-on Acquisition 10 of 15
State: Connecticut 1 of 1
Country: United States 8 of 11
Year: 2016 2 of 3
Size (of disclosed) 7 of 15
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-02-03 NAMSA - Sterility Assurance Monitoring Products Division

United States

NAMSA - Sterility Assurance Monitoring Products Division is a manufacturer of high-quality biological and chemical indicators which are used to accurately monitor the effectiveness of sterilization processes. Its domestic and international market segments include pharmaceutical, medical device, contract sterilizers, laboratories, health care, dental, food and beverage, and biotech companies.

Buy $14M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-09-26 Vantage Endoscopy - Endoscopy Assets

Kitchener, Ontario, Canada

Vantage Endoscopy, Inc. - Endoscopy Assets is a provider of medical products.

Buy -